Investigation of thyroid, head, and neck cancers with PET

Radiol Clin North Am. 2004 Nov;42(6):1101-11, viii. doi: 10.1016/j.rcl.2004.07.006.


PET with [(18)F]-fluorodeoxyglucose (FDG) has been accepted as a useful imaging modality for the diagnosis of a variety of malignancies. This article discusses the use of FDG-PET in the management of patients with thyroid and head or neck cancers.

Publication types

  • Review

MeSH terms

  • Fluorodeoxyglucose F18
  • Head and Neck Neoplasms / diagnostic imaging*
  • Head and Neck Neoplasms / therapy
  • Humans
  • Neoplasm Recurrence, Local / diagnostic imaging
  • Neoplasm Staging
  • Positron-Emission Tomography*
  • Radiopharmaceuticals
  • Thyroid Neoplasms / diagnostic imaging*
  • Thyroid Neoplasms / therapy
  • Treatment Outcome


  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18